Sana Biotechnology (SANA) Change in Acquisitions & Divestments (2020 - 2026)
Sana Biotechnology (SANA) reported Change in Acquisitions & Divestments of $55.1 million for Q1 2026, up 203.09% on a YoY basis from $18.2 million in Q1 2025, and up 178.11% sequentially from $19.8 million in Q4 2025.
Sana Biotechnology (SANA) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Sana Biotechnology (SANA) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $55.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 203.09% year-over-year to $55.1 million; the trailing twelve-month figure through Mar 2026 stood at $83.5 million (down 65.53% YoY), and the FY2025 full-year result was $46.6 million, down 83.19% from the prior year.
- Change in Acquisitions & Divestments rose to $55.1 million in Q1 2026, from $19.8 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $113.9 million in Q3 2023 to a low of $1.4 million in Q3 2025.
- A 5-year average of $61.1 million and a median of $55.5 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments surged 727.67% in 2022 and slumped 98.28% in 2025, its largest moves.
- Tracing SANA's Change in Acquisitions & Divestments over 5 years: stood at $108.1 million in 2022, then plunged by 48.69% to $55.5 million in 2023, then rose by 9.22% to $60.6 million in 2024, then slumped by 67.33% to $19.8 million in 2025, then jumped by 178.11% to $55.1 million in 2026.
- Business Quant data shows SANA's Change in Acquisitions & Divestments at $55.1 million in Q1 2026, $19.8 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Sana Biotechnology | 923.31 Mn | 923.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.07 Mn |
| Mar 31, 2026 | 55.07 Mn |
| Dec 31, 2025 | 19.80 Mn |
| Dec 31, 2025 | 19.80 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 7.19 Mn |
| Jun 30, 2025 | 7.19 Mn |
| Mar 31, 2025 | 18.17 Mn |
| Mar 31, 2025 | 18.17 Mn |
| Dec 31, 2024 | 60.60 Mn |
| Dec 31, 2024 | 60.60 Mn |
| Sep 30, 2024 | 81.84 Mn |
| Sep 30, 2024 | 81.84 Mn |
| Jun 30, 2024 | 81.50 Mn |
| Jun 30, 2024 | 81.50 Mn |
| Mar 31, 2024 | 53.01 Mn |
| Mar 31, 2024 | 53.01 Mn |
| Dec 31, 2023 | 55.48 Mn |
| Dec 31, 2023 | 55.48 Mn |